Physician profile
Mert Dinc
NPI 1346376787
$11,585.67
in general payments reported to CMS, 2019-2025
25 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $3,348 · 2021: $5,575 · 2022: $279 · 2023: $121 · 2024: $46.01 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,902.51 | 2019-2023 | Liletta |
| Minerva Surgical, INC | $1,340.32 | 2019-2023 | |
| Allergan, INC. | $143.44 | 2019-2020 | |
| Olympus America INC. | $114.72 | 2020 | |
| Baxter Healthcare | $113.01 | 2025 | Tisseel |
| Mylan Pharmaceuticals INC. | $104.50 | 2019-2022 | |
| Apyx Medical Corporation | $94.43 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $88.63 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Therapeuticsmd, INC. | $87.56 | 2019-2022 | |
| Organon LLC | $87.16 | 2021-2024 | Nexplanon |
| Coopersurgical, INC. | $84.25 | 2019 | |
| Valencia Technologies Corporation | $81.90 | 2025 | Ecoin Device Kit |
| Aspira Women'S Health INC | $73.38 | 2021 | |
| Lupin INC. | $52.00 | 2020 | |
| Zyla Life Sciences, INC. | $34.83 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $27.06 | 2022-2023 | Myrbetriq |
| Becton, Dickinson and Company | $21.19 | 2022 | |
| Roche Diagnostics Corporation | $20.55 | 2019 | |
| Pfizer INC. | $19.80 | 2021 | |
| Vertical Pharmaceuticals, LLC | $19.54 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.61 | 2019 | |
| Avion Pharmaceuticals | $18.55 | 2022 | |
| Novo Nordisk INC | $17.12 | 2020 | |
| Dysis Medical, INC. | $12.90 | 2022 | |
| Meditrina | $7.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mert Dinc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.